the confidential, anonymous submission by officers or employees of the Company or others or concerns regarding questionable accounting or auditing matters.

Have there been any previous lawsuits against the company regarding environmental concerns? Yes ​ No ​. If yes, please describe how these lawsuits were resolved?

6、 Party B shall carry out safety publicity, education and training, improve the safety awareness of all staffs, and maintain the safety management of Wenzhou Yangfushan sailing boat marina.

Each Party shall # promptly inform the other Party of any communication made to, or received by such Party from, any Governmental Entity or members of its staff regarding any of the transactions contemplated hereby, # respond as promptly as reasonably practicable to any inquiries or requests for additional information and documentary material received from any Governmental Entity or members of its staff, # except as required by applicable Law, and except with written consent of the other Party, not enter into any agreement with any Governmental Entity agreeing not to consummate the transactions contemplated by this Agreement, and # promptly inform the other Party of any communication made to, or received by such Party from, any Governmental Entity or members of its staff regarding any Environmental, Health and Safety Law.

“Commercially Reasonable Efforts” means those efforts commensurate with those efforts commonly used in the biopharmaceutical industry by a company of comparable size in connection with the development, manufacturing or commercialization of products that are of similar status, including market potential, profit potential and strategic value, as determined based on conditions then prevailing, including safety, efficacy, competitive considerations within the marketplace, projected market size, intellectual property protection and duration, manufacturing costs, resource allocation, pricing, re-importation concerns, regulatory requirements needed to achieve Regulatory Approval, and other relevant commercial and regulatory considerations, provided that no other anti-PD-1 antibody product being developed, manufactured, or commercialized by Arcus or its Affiliates (including any acquiring entity) will be taken into consideration in connection with determining such efforts.

Termination by Allergan. Allergan may terminate this Agreement # upon ​ days’ prior written notice to UroGen if such notice is given prior to the First Commercial Sale of a Licensed Product in a country in the Territory or # upon ​ days’ prior written notice to UroGen if such notice is given following the First Commercial Sale of a Licensed Product in a country in the Territory, provided that, for clarity and without limiting any other right of Allergan under this Agreement, Allergan shall at all times have the right to suspend or discontinue the use of any Licensed Product for bona fide safety or efficacy concerns immediately upon Allergan’s delivery to UroGen of a notice of termination under this Section 11.2.2.

The operating unit and performance results will be communicated throughout the organization to the extent that the Company deems appropriate and subject to any confidentiality concerns.

Health & Safety. Failure to provide workers a workplace that meets applicable health, safety and security standards.

“Occupational Safety and Health Law Claim” means any claim arising under the Occupational Safety and Health Law.

•Safety & Sustainability - Risk Reduction: the safety and sustainability measure is based on the effectiveness of the Company’s Environmental, Health and Safety management system for the Phosphates and Potash business units, and has a weighting of 10% for executive officers.